Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pyrophosphoric acid is a phosphorus oxoacid with the chemical formula H4P2O7. It is a colorless, odorless, viscous, and highly water-soluble solid or liquid at room temperature. Structurally, it consists of two phosphate groups joined by an oxygen bridge. Pyrophosphoric acid is a tetraprotic acid (can donate four protons) and exists as various protonated forms depending on pH[1][6]. In medicine, it serves as an ingredient in radiopharmaceuticals used for imaging bone and cardiovascular abnormalities and has been included in products to prevent iron deficiency anemia[3]. Mechanistically, it can act as an inhibitor of farnesyl pyrophosphate synthase[3]. Outside pharmaceuticals, it finds use in fertilizer production (enhancing phosphorus availability), food processing (as stabilizer/acidity regulator), biochemical research (especially nucleotide/nucleic acids studies), water treatment (removal of heavy metals), catalysis, metal refining, and as a complexing agent for metal ions like iron[5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pyrophosphoric acid.